Plain-English translation of NCT05961982 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) — a minimally invasive treatment that uses heat delivered through an ultrasound camera to treat pancreatic cysts that have concerning features. The treatment is being studied in patients who cannot or prefer not to have surgery to remove these cysts. Researchers want to see how well and how safely this treatment works over time.
Pancreatic cysts with worrisome features can develop into cancer, but surgery to remove them carries high risk for some patients — especially older adults, those with serious health conditions, or those with liver disease. This trial exists to offer a safer alternative treatment option for these patients.
You likely qualify if…
You likely don't qualify if…
You will undergo a procedure where doctors use an ultrasound-guided camera passed through your mouth to reach your pancreas, take a small tissue sample (if needed), and then deliver heat treatment to shrink the cyst. You may need repeat treatments during follow-up care. After treatment, you will have imaging scans (MRI, CT, or ultrasound) at baseline and at scheduled follow-up visits every 3 to 6 months (for larger cysts) or every 6 to 12 months (for smaller cysts) for up to 3 years to monitor how well the treatment is working.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States